{"canonical":"https://abierto.us/vendors/bioaegis-therapeutics-inc-g2azac2pg7x3","key":"G2AZAC2PG7X3","name":"BIOAEGIS THERAPEUTICS INC","uei":"G2AZAC2PG7X3","city":"MORRISTOWN","state":"NJ","awards":1,"obligated":"0","notices_won":0,"top_agency_name":"Office of Assistant Secretary for Preparedness and Response","top_naics":"541715","cage":"6QA91","parent_name":"BIOAEGIS THERAPEUTICS INC","also_known_as":[],"country":"USA","actions":1,"first_action":"2026-07-13","last_action":"2026-07-13","breakdowns":{"naics":[{"key":"541715","name":null,"awards":1,"obligated":"0.00"}],"places":[{"key":"NJ","name":null,"awards":1,"obligated":"0.00"}],"agencies":[{"key":"7505","name":"Office of Assistant Secretary for Preparedness and Response","awards":1,"obligated":"0.00"}],"award_types":[{"key":"DEFINITIVE CONTRACT","name":null,"awards":1,"obligated":"0.00"}],"competition":[{"key":"FULL AND OPEN COMPETITION","name":null,"awards":1,"obligated":"0.00"}],"product_service_codes":[{"key":"AN13","name":null,"awards":1,"obligated":"0.00"}]},"awards_list":[{"award_key":"CONT_AWD_75A50123C00067_7505_-NONE-_-NONE-","permalink":"https://www.usaspending.gov/award/CONT_AWD_75A50123C00067_7505_-NONE-_-NONE-/","piid":"75A50123C00067","parent_piid":null,"award_type":"DEFINITIVE CONTRACT","vendor_key":"G2AZAC2PG7X3","recipient_name":"BIOAEGIS THERAPEUTICS INC","recipient_uei":"G2AZAC2PG7X3","recipient_cage":"6QA91","recipient_city":"MORRISTOWN","recipient_state":"NJ","sub_name":"Office of Assistant Secretary for Preparedness and Response","office_name":"BARDA - ASPR / DAAPPO / BARDA DCMA","office_key":"o-75A501","first_action_date":"2026-07-13","last_action_date":"2026-07-13","actions":1,"obligated":"0","current_total_value":"20000000.00","potential_total_value":"20000000.00","naics":"541715","psc":"AN13","extent_competed":"FULL AND OPEN COMPETITION","set_aside":"NO SET ASIDE USED.","offers_received":100,"description":"BIOAEGIS: PLASMA GELSOLIN (PGSN), AN ABUNDANT, CIRCULATING PROTEIN MODULATES INFLAMMATION WHILE ALSO ENHANCING HOST DEFENSES BY STIMULATING THE UPTAKE AND KILLING OF PATHOGENS. CLINICAL STUDIES HAVE CONSISTENTLY SHOWN PGSN IS DEPLETED IN SEVERE I","method":null,"confidence":null,"evidence":null,"opportunity_key":null,"opportunity_title":null}],"awards_total":1,"awards_page":1,"won":[],"won_total":0,"solicitations_won":[]}